Literature DB >> 11923481

Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers.

Gregor Bahrenberg1, Iris Behrmann, Andreas Barthel, Paul Hekerman, Peter Claus Heinrich, Hans-Georg Joost, Walter Becker.   

Abstract

Two predominant splice variants of the leptin receptor (LEPR) are coexpressed in leptin-responsive tissues: the long form, LEPRb, characterized as the signal-transducing receptor, and the signaling-defective short form, LEPRa. It is unknown whether heterodimers of these isoforms are capable of signal transduction via the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. To address this question, chimeric receptors were constructed consisting of the transmembrane and intracellular parts of LEPRb and LEPRa fused with the extracellular domains of either the alpha- or beta-subunit of the IL-5 receptor. This strategy allows the directed heterodimerization of different LEPR cytoplasmic tails and excludes homodimerization. In COS-7 and HEPG2 cells, chimeric receptor heterodimers of LEPRa and LEPRb failed to activate the JAK/STAT pathway, whereas receptor dimers of LEPRb gave rise to the expected ligand-dependent activation of JAK2, phosphorylation of STAT3, and STAT3-dependent promoter activity. Markedly lower amounts of JAK2 were found to be associated with immunoprecipitated LEPRa chimeras than with LEPRb chimeras. Analysis of a series of deletion constructs indicated that a segment of 15 amino acids in addition to the 29 amino acids common to LEPRa and LEPRb was required for partial restoration of JAK/STAT activation. Site-directed mutagenesis of the critical sequence indicated that two hydrophobic residues (Leu896, Phe897) not present in LEPRa were indispensable for receptor signaling. These findings show that LEPRa/LEPRb heterodimers cannot activate STAT3 and identify sequence elements within the LEPR that are critical for the activation of JAK2 and STAT3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923481     DOI: 10.1210/mend.16.4.0800

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  33 in total

1.  SH2B1--the adaptor protein that could.

Authors:  Streamson Chua
Journal:  Endocrinology       Date:  2010-09       Impact factor: 4.736

Review 2.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

Review 3.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

4.  PI3K integrates the action of insulin and leptin on hypothalamic neurons.

Authors:  Allison Wanting Xu; Christopher B Kaelin; Kiyoshi Takeda; Shizuo Akira; Michael W Schwartz; Gregory S Barsh
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

Review 5.  Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network.

Authors:  Kevin W Williams; Michael M Scott; Joel K Elmquist
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

6.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

7.  Functional consequences of the human leptin receptor (LEPR) Q223R transversion.

Authors:  George Stratigopoulos; Charles A LeDuc; Naoki Matsuoka; Roee Gutman; Richard Rausch; Scott A Robertson; Martin G Myers; Wendy K Chung; Streamson C Chua; Rudolph L Leibel
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

Review 8.  BDNF and the central control of feeding: accidental bystander or essential player?

Authors:  Maribel Rios
Journal:  Trends Neurosci       Date:  2013-01-18       Impact factor: 13.837

9.  A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells.

Authors:  Tuba Ozbay; Rita Nahta
Journal:  Mol Cancer Res       Date:  2008-05-30       Impact factor: 5.852

10.  Leptin and leptin receptor expression in breast cancer.

Authors:  Hee Sung Kim
Journal:  Cancer Res Treat       Date:  2009-09-28       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.